Repro-Med Systems, Inc. (OTCMKTS:REPR) Director Joseph M. Jr. Manko acquired 33,000 shares of the company’s stock in a transaction dated Monday, November 19th. The stock was bought at an average cost of $1.57 per share, for a total transaction of $51,810.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Shares of REPR traded down $0.06 during trading hours on Monday, hitting $1.53. The company had a trading volume of 33,467 shares, compared to its average volume of 28,537. Repro-Med Systems, Inc. has a 12 month low of $0.70 and a 12 month high of $1.80.

Repro-Med Systems (OTCMKTS:REPR) last issued its quarterly earnings data on Wednesday, October 24th. The company reported $0.01 earnings per share for the quarter. The company had revenue of $4.55 million during the quarter.

TRADEMARK VIOLATION WARNING: This report was first reported by Daily Political and is owned by of Daily Political. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this report can be read at

About Repro-Med Systems

Repro Med Systems, Inc designs, manufactures, and markets proprietary portable medical devices and supplies primarily for the ambulatory infusion market and emergency medical applications worldwide. The company offers mechanical infusion product FREEDOM infusion systems, which include the FREEDOM60 syringe infusion driver, the FreedomEdge syringe infusion driver, HIgH-Flo subcutaneous safety needle sets, RMS precision flow rate tubing, and RMS precision flow rate controller, as well as medical suction product RES-Q-VAC, a portable medical suction system.

Featured Article: How To Calculate Debt-to-Equity Ratio

Insider Buying and Selling by Quarter for Repro-Med Systems (OTCMKTS:REPR)

Receive News & Ratings for Repro-Med Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Repro-Med Systems and related companies with's FREE daily email newsletter.